The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
whats funny tom is when you were buying at 80p it had already risen 100%... some may of thought that it was high at the time, slight pullback/consolidation period and its off again breaking through previous resistance around £1. soon it will be £1.60 giving you a 100% return and new investors will be looking at it thinking it could be looking high and i think it will double easily from there too!! market is just picking up on the potential and with the board being very quiet i think the real movement up hasn't even started yet. whats it going to take the FDA news for people to come here? hmmm. by that time I'm sure all who's bought in already will be smiling if theyre still holding.
and anyway who doesnt like a quiet board without all the numpties, seeing the sp climb slowly each week :)
i completely agree with your friend ;) with news that is up and coming and follow on contracts with the big pharma companies then the sp will only go from strength to strength. i would say short term within a year so med term could be anything after this up to a few years. some 'investing' on the aim market would think med term would be over a week!!
best bit of advice would be to dive into all the news for research and see if this company is for you. and it could turn out to be a ftse company in the making :)
cripiano thry wont be on that mcap with current shares. they will dilute over the years to fund growth until theyre in a position to fund growth organically with growing revenues/profit . i dont mind placing and funraises if it funds growth instead of lining the BODs pocket within a lifestyle company. i wouldnt even be consider thinking about a $5M company. that valuation is huge and will take AGL a few years to even come close to that kind of mcap. i personally would be viewing the $1B valuation a possibility and within the med term. if things go the way we hope i think we will soon come into an avalanche of newflow boosting SP each step.
looking back at the previous share options allocated to Andrew and Ian it shows you where they'll be wanting to drive the company to unlock the options.
2020 options- SP price of £1.80 to gain 100% of options, avaliable from 2023
2018 options- SP price of £2.07 to gain 100% of options, avaliable from 2021
2016 options- SP price of £1.29 to gain 100% of option, avaliable now
when the 2016 options get vested i would like to see AN and ian taking up these options. other ones do not vest until end of this year and into 2023.
but anyone who thinks theyve missed the boat already look at these prices the BOD will be wanting to achieve to benefit them. and also look at the huge trades going through at 110p yesterday. iis still loading up at these levels why shouldnt we ;)
i wouldnt be surprised if our friends across the pond started to buy when their markets opened up. same thing happened after the rns on friday where we seen a nice climb first thing, consolidate then big push in the afternoon right into close. hopefully we will see the same today confirming the yankie doodles are happy to buy up stock at this level.
either way its all looking good. :)
Bmdjf it suspended at $4.50HK so roughly 4.5p without looking up current exchange rates. but that means bugger all. we have to see when we relist and see what price the HK investors puts our sp after results. will there be a big sell off not trusting BOD and comp or will it be brushed off after results and may even rise? god knows. guess not much point worrying about it until relist day
Top i wouldnt count on getting anything back if we did delist. companies dont get.teo hoots about shareholders. ive been in a few companies who delisted completely and shareholders got diddle squat. the BOD always win out of it selling assets off after it delists. but when it delists it more or less becomes a private company with ownership going to biggest shareholders who will all benefit from it.
lets hope thats not an option!!
haha yup MissBMW theres a few of us oldies still hanging around (not age related!!) i guess many thought the real movement would of been here already if you looked back a few years ago but happy with the progress overall. everyone would love for their shares to really motor and it then gives you a complex, do you bank the profits or do you let the investment run. i suppose everyone is different and everyone has different targets to sell or top slice and rightly so. we'd have the uptrends and followed by long periods of low newsflow creating the bear trend which which lasted a couple years until the crazy lows of the 40s... now the shift in movement is definitely moving in the right direction and has a better feel to the overall bull trend were in.
its going to be fun when it finally punches through the £1 level entering into new range. next couple of weeks- months should bring in new investors taking up a position and looking for a return a lot bigger than the £1 level, which can only benefit all whos currently in profit or close to.
from memory they also have china and australia. so huge market.
also have a european patent for megakaryocyte analsysis but option expiries june this year so i expect further news on that later in the year.
all it takes is a few big pharmas/medtech comps to get contracts flowing to AGL and we'll see a massive rerate on sp. thats without the up and coming FDA approval news and possible future listing on NASDAQ. even without considering all other future cancer approvals for parsortix after breast cancer.
huge numbers is a possibility. is this just the start of a long long growth story for AGL!!
hard works already been done on AGL getting to this stage over the years and years of proving the IP and becoming a respectable company. not a company whos all talk and have nothing but hot air!
for those whos been here a while have believed in AGL. have believed in A.N and believed in the tech. its slowly turning into a billion $ company
cash in the bank of £4M aint too shabby for a company with a MCAP of around £26M
with a net assets of around £24m the current sp doesnt reflect cash in the bank, and also the 40 backlog projects worth around £80m.
i would say its still way undervalued at current 4.5p (give or take a bit for exchange rates for all figures)
lets hope they can put to bed this money thats been enquired about and market likes the results hopefully forgetting about this suspension carry on.
nice to see a steady climb today and what looks like american investors jumping in when their markets opened at midday uk time. nice steady climb into close of play and we'll soon be testing that £1 level in no time. could be a nice climb and steady rise until webcast and depending how well AN is recieved on the webcast there could be more momentum building up the SP.
and another cheeky contract from another pharma/medtech comp wouldnt go a miss but at the moment im more than happy with the first being signed very shortly after the clinics opened. goes to show a lot of talks going on behin doors. and AN did mention AGL are in talks with multiple customers :) first of many before FDA would be super duper.
what really surprises me is the deadly silence on the tiger on the leash. without proper news flow coming from italy or even power station you would think theyd be banging on the 'tiger on the leash' drum to boost sp then raise. but total news blackout on that and no mention at all. i wonder why theyre quite on that considering a couple of years back its all they banged on about at every chance they can get and at every foot note on each RNS. now.... nothing.
whats happened to it!